Chemokine-targeted therapies: An opportunity to remodel immune profiles in gastro-oesophageal tumours
Citation:
O'Donovan, Davern M., Donlon N.E., Lysaght J and M.J. Conroy, Chemokine-targeted therapies: An opportunity to remodel immune profiles in gastro-oesophageal tumours, Cancer Letters, 2021Download Item:
Abstract:
Immunotherapies are transforming outcomes for many cancer patients and are quickly becoming the fourth pillar of cancer therapy. However, their efficacy of only ∼25% in gastro-oesophageal cancer has been disappointing. This is attributed to factors such as insufficient patient stratification and the pro-tumourigenic immune landscape of gastro-oesophageal tumours. The chemokine profiles of solid tumours and the availability of effector immune cells greatly influence the immune infiltrate, producing 'cold' or 'immune-excluded' tumours in which immunotherapies are unable to reinvigorate the immune response. Other biological functions for chemokines have emerged, such as promoting cell survival, polarising T cell responses, and supporting several hallmarks of cancer. Therefore, chemokine networks may be exploited with therapeutic intent to mobilise and polarise anti-tumour immune cells, with further utility as combination treatments to augment the efficacy of current cancer immunotherapies. Few studies have demonstrated the clinical benefit of chemokine-targeted therapies as monotherapies, and this review proposes their consideration as combination treatments. Herein, we explore the anti-tumour and pro-tumour implications of chemokine signalling in gastro-oesophageal cancer and discuss their value as prognostic and predictive biomarkers in response to treatment.
Author's Homepage:
http://people.tcd.ie/meconroyDescription:
PUBLISHED
Author: Conroy, Melissa
Type of material:
Journal ArticleCollections
Series/Report no:
Cancer LettersAvailability:
Full text availableSubject (TCD):
Cancer , Identities in Transformation , Biomedical sciences , CANCER , Tumour immunology and immunotherapyDOI:
https://doi.org/10.1016/j.canlet.2021.09.005ISSN:
PMID: 34506844Metadata
Show full item recordLicences: